NFE2L2 and pancreatic neoplasm: Results from previous studies have indicated that apoptosis observed in targeting the Nrf2 pathway is usually a consequence of ROS production; however, NSC84167 induced limited ROS in both sensitive and resistant pancreatic cancer cell lines.